Takeda Presents 18-Month Data from Pivotal Phase 3 Trial of Dengue Vaccine Candidate at the American Society of Tropical Medicine and Hygiene (ASTMH) 68th Annual Meeting - BioSpace

Takeda Presents 18-Month Data from Pivotal Phase 3 Trial of Dengue Vaccine Candidate at the American Society of Tropical Medicine and Hygiene (ASTMH) 68th Annual Meeting  BioSpace

Comments

Popular posts from this blog

SARS-CoV-2 virus may be shed for much longer periods by some infected patients, study shows - News-Medical.Net

This Nurse Built a Clinic in the Sierra Leone Village Where She Grew Up. That’s Just the Beginning. - Direct Relief